CJC-1295

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), designed to stimulate the natural production and sustained release of growth hormone. It is often studied for its extended half-life, particularly in its DAC (Drug Affinity Complex) form, allowing for prolonged activity in the body.

This peptide has been studied for its potential to:

• Increase natural growth hormone secretion
• Support improved muscle development and recovery
• Promote fat metabolism and body composition improvements
• Enhance overall recovery and cellular repair processes

CJC-1295 works by binding to GHRH receptors in the pituitary gland, encouraging a more consistent release of growth hormone rather than sharp spikes. Its extended activity profile makes it a key focus in research related to performance optimization, recovery, and metabolic health.